Related Experiment Videos
Activity of nitric oxide-generating compounds against encephalomyocarditis virus
E Guillemard1, M Geniteau-Legendre, R Kergot
1Laboratoire de Virologie et Immunologie Expérimentales, Centre d'Etudes Pharmaceutiques de Châtenay-Malabry, France.
Antimicrobial Agents and Chemotherapy
|April 1, 1996
Summary
Nitric oxide (NO) inhibits encephalomyocarditis virus replication in L-929 cells. This antiviral effect is not due to cell toxicity or direct virus inactivation by NO donors.
Area of Science:
- Virology
- Immunology
- Biochemistry
Background:
- Encephalomyocarditis virus (EMCV) is a significant pathogen.
- Nitric oxide (NO) plays diverse roles in cellular processes.
- The antiviral potential of NO requires further elucidation.
Purpose of the Study:
- To investigate the effect of nitric oxide (NO) on encephalomyocarditis virus (EMCV) replication.
- To determine if NO donors exhibit antiviral activity against EMCV in L-929 cells.
- To explore the mechanism of NO's antiviral action.
Main Methods:
- Treatment of L-929 cells with NO donors (sodium nitroprusside, S-nitroso-L-glutathione).
- Quantification of EMCV growth.
- Assessment of cell viability and direct virucidal effects.
Main Results:
- NO donors demonstrated a dose-dependent inhibition of EMCV replication.
- NO's antiviral effect was independent of cytotoxicity or direct virucidal activity.
- Endogenous NO production by L-929 cells was insufficient to inhibit EMCV replication.
Conclusions:
- Nitric oxide possesses significant antiviral properties against EMCV.
- NO-mediated inhibition of viral replication is a key mechanism of host defense.
- Exogenous NO administration may represent a therapeutic strategy against EMCV infections.